Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Olodaterol/tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 22 Jan 2018 Planned End Date changed from 28 Feb 2018 to 15 Jun 2018.
- 22 Jan 2018 Planned primary completion date changed from 28 Feb 2018 to 15 Jun 2018.
- 04 May 2017 Status changed from not yet recruiting to recruiting.